Mark A Novotny

Title: Mark A Novotny: Innovator in Venous Air Embolism Detection

Introduction

Mark A Novotny is a notable inventor based in Westminster, CO (US). He has made significant contributions to the field of medical technology, particularly in the detection of venous air emboli (VAE). His innovative approach combines various measurements to enhance patient safety during medical procedures.

Latest Patents

Mark A Novotny holds a patent for a "Method and apparatus for detection of venous air emboli." This invention utilizes concomitant measurements of end-tidal carbon dioxide (EtCO₂), end-tidal nitrogen (EtN₂), and the difference between inspired and expired oxygen concentrations to detect VAE. The system continuously monitors these gas concentrations, averages them over a predetermined time period, and stores the data for historical reference. The device signals the presence of a venous air embolism when specific conditions are met, including a decrease in EtCO₂ concentration, an increase in FeN₂ concentration, and a decrease in the difference between inspired and expired oxygen concentrations.

Career Highlights

Mark A Novotny is associated with Ohmeda Inc., a company known for its advancements in medical technology. His work has contributed to improving patient monitoring systems, making them more reliable and effective in detecting potential complications during medical procedures.

Collaborations

Some of his notable coworkers include Thomas A Boone and Garfield B Russell. Their collaboration has likely fostered an environment of innovation and shared expertise in the field of medical technology.

Conclusion

Mark A Novotny's contributions to the detection of venous air embolism represent a significant advancement in medical technology. His innovative patent and work at Ohmeda Inc. highlight his commitment to enhancing patient safety and monitoring systems.